drugset / Trial / NCT07375342

Melatonin for Post Tonsillectomy Emergence Agitation in Pediatric

NCT07375342

Recruiting 120 enrolled Benha University
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The goal of this clinical trial is to learn if melatonin can decrease emergence agitation in pediatric post tonsillectomy. The main questions it aims to answer are: Does melatonin decrease emergence agitation in pediatric post tonsillectomy? What medical problems do participants have when taking melatonin? Researchers will compare melatonin to a placebo (a look-alike substance that contains no drug) to see if melatonin works todecrease emergence agitation in pediatric post tonsillectomy Participants will receive Oral melatonin at a dose of 0.5 mg/kg (maximum 20 mg) administered 30 minutes before induction of anesthesia. Dose chosen based on prior pediatric studies and safety data.

Timeline

Start
2025-12-10
Primary completion
2026-05-01
Completion
2026-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Melatonin Small molecule 0.5 mg/kg Oral

Indications

No indication recorded.